Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-025448

Director bought 75,000 shares at $2.00 ($150,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schoeneck James A Director 2025-08-21 Purchase +75,000 $2.00 $150,000 76,134 D
Derivatives
Schoeneck James A Director 2025-08-21 Purchase · Warrant (right to buy) +75,000 75,000 D
Open-market purchases · 75,000 sh · avg $2.00 · $150,000
Loading xslF345X05/ownership.xml…